PD-1抑制剂联合瑞戈非尼治疗结直肠癌患者药物不良反应的护理
作者:
作者单位:

作者简介:

女,本科,主管护师

通讯作者:

基金项目:

天津市医学重点学科(专科)建设项目(TJYXZDXK-011A);天津市卫生健康科技项目(TJWJ2021MS007)


Nursing care of patients developing adverse reactions from combination regimen of PD-1 inhibitor and Regorafenib for colorectal cancer
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    对126例转移性结直肠癌患者接受治疗过程中出现的 37例(29.37%)药物不良反应,包括皮肤毒性反应10例、消化道反应10例、疲乏8例、口腔黏膜炎4例、高血压3例、血小板减少2例,给予严密观察,准确分级,并根据分级实施针对性的护理措施。 经及时发现和处置后,22例患者不适症状均得到缓解,顺利完成治疗;15例终止或放弃治疗。

    Abstract:

    In 126 cases of metastatic colorectal cancer patients treated with combination regimen,37 cases (29.37%) developed adverse drug reactions, including 10 cases of skin toxic reactions, 10 cases of gastrointestinal reactions, 8 cases of fatigue, 4 cases of oral mucositis, 3 cases of hypertension, and 2 cases of thrombocytopenia.The cases were closely observed, accurately graded, and targeted nursing measures were implemented according to the gradings.After timely detection and treatment, 22 patients′ symptoms were relieved and combination treatment was successfully completed, while 15 cases terminated or aborted treatment.

    参考文献
    相似文献
    引证文献
引用本文

李千红,李艳,张赛娜. PD-1抑制剂联合瑞戈非尼治疗结直肠癌患者药物不良反应的护理[J].护理学杂志,2023,38(15):27-30

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2023-03-02
  • 最后修改日期:2023-05-10
  • 录用日期:
  • 在线发布日期: 2023-12-29